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Origins and formation of microvasculature in the developing
kidney. Regulation of microvessel assembly in the developing
kidney is not known and may occur through vasculogenic, angio-
genic, or both processes. To examine this question, we grafted rat
and mice embryonic (E) day 12 (E12) kidneys, which have only a
rudimentary vasculature, into anterior eye chambers of mouse
and rat hosts. Species-specific, monoclonal anti-basement mem-
brane antibodies showed that glomerular basement membranes,
mesangial matrices, and microvessel basement membranes were
always derived from the graft. When wild-type E12 mouse kidneys
were grafted into anterior chambers of ROSA26 mice, in which
the b-galactosidase transgene is expressed ubiquitously, glomer-
ular and microvascular endothelial cells stemmed from the graft,
even after maintenance of kidneys in organ culture for 6 days
before grafting. Immunolabeling with antibodies against the vas-
cular endothelial growth factor (VEGF) receptor, Flk1, the
EphB1 receptor, and its ligand, ephrin-B1, labeled discrete mes-
enchymal cells in embryonic and newborn kidney cortex, as well as
developing microvessel and glomerular endothelium. In adult
kidneys, Flk1 labeled glomeruli weakly, other vascular structures
were unlabeled. When wild-type E12 kidneys were grafted under
renal capsules of adult ROSA26 hosts, endothelium developing
within the graft again came from the implanted kidney. In
contrast, when E12 kidneys were grafted into renal cortices of
newborns, glomeruli within grafts now contained host-derived
endothelium. Similarly, when ROSA26 E12 kidneys were im-
planted into newborn wild-type hosts, chimeric vessels containing
graft- and host-derived endothelium were seen in nearby host
tissue. Our results indicate that cells capable of forming the entire
microvascular tree of grafted metanephroi are already present in
the E12 kidney. We hypothesize that Flk1/VEGF and EphB1/
ephrin-B1 mediate renal endothelial mitosis-motility and cell
guidance-aggregation behavior, respectively.
EMBRYONIC KIDNEY VASCULARIZATION
The renal microvasculature is an intricate, reiterated
system of microvascular units that envelops each of the
;1-million nephrons in each human kidney. Each nephron
microvascular unit consists of an afferent glomerular arte-
riole, a glomerular capillary tuft, an efferent glomerular
arteriole, and a peritubular capillary bed. Once the full
complement of nephrons has formed during kidney orga-
nogenesis, there is severely limited ability to repair injured
glomeruli and no capacity whatsoever to generate new
glomeruli to replace those that become irretrievably dam-
aged. In addition, uncontrolled hypertension and diabetes
invariably lead to renal arteriolosclerosis and glomerulo-
sclerosis, which result in renal failure. Despite the impor-
tance of the renal microvasculature, the fundamental
mechanisms accounting for its initial formation during
organogenesis, and maintenance thereafter, are not known.
Development of the permanent, metanephric kidney in
the mouse begins on embryonic day 11 (E11). At this time,
the ureteric bud, which is an epithelial tube derived from
the nephric duct, grows into the metanephric mesenchyme
and undergoes a series of dichotomous branches. At the
tips of each branch, mesenchymal cells are induced to
aggregate [1, 2]. Each mesenchymal cell aggregate rapidly
assumes an epithelial phenotype and becomes an early
nephric figure referred to as a “vesicle” that subsequently
develops into a nephron. On the lower aspect of the vesicle,
a groove termed the vascular cleft develops, and endothe-
lial precursors migrate into this cleft to begin forming the
glomerular capillary tuft.
Saxe´n has reviewed the two probable embryonic sources
for the glomerular endothelium [3]. First, metanephric
mesenchymal cells may migrate into the vascular cleft and,
by vasculogenesis, establish the glomeruli. Vasculogenesis
is the process whereby dispersed, mesodermally-derived
endothelial precursor cells (angioblasts) coalesce in situ to
form a network of channels that then connect to larger
vessels [4]. The possibility that glomerular endothelium
stems from metanephric vasculogenic angioblasts was
raised on the basis of earlier morphologic investigations,
but until very recently, there was no direct experimental
support. A second possible source for embryonic kidney
endothelial cells is from the ingrowth of tubelike angio-
genic sprouts derived from external vessels. Support for this
second possibility comes from interspecific grafts of fetal
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kidneys onto avian chorioallantoic membrane (CAM) [6], a
site that provides a rich vascular bed to sustain the graft.
When E11 mouse kidneys are grafted onto chick CAM and
labeled with species-specific anticollagen type IV antibod-
ies, both antichick and antimouse antibody bind to the
glomerular basement membranes (GBMs) of glomeruli
forming in these grafts, but mesangial matrices only label
with the antichick antibody [6]. Separate experiments
showed that when mouse kidneys are grafted onto quail
CAM, glomerular endothelial cells contain the prominent
quail nucleolar marker [7]. Conclusions drawn from these
studies are that both epithelial and endothelial cells con-
tribute to the GBM and that there is an exogenous origin
for renal endothelial and mesangial cells, which presumably
stem from ingrowing angiogenic sprouts [6, 7]. Some prob-
lems acknowledged in these studies were that few mamma-
lian glomeruli develop in ovo and that, in general, no
full-blown glomeruli are seen [6, 7]. These earlier experi-
ments also lack a method for the unambiguous detection of
donor-produced endothelium, and they were carried out at
a time when there was little awareness of angioblasts or the
process of vasculogenesis and when markers for early
endothelial cells were not available.
ANTERIOR CHAMBER GRAFTS OF EMBRYONIC
KIDNEYS
To reexamine the embryonic origins of renal glomerular
endothelial cells, we established interspecies grafts between
rats and mice in which embryonic kidneys were implanted
into anterior eye chambers of adult hosts [8]. After five to
seven days, hosts then receive i.v. injections of species-
specific monoclonal antibodies against either rat- or
mouse-produced basement membrane proteins. In all
cases, GBMs, mesangial matrices, and microvessel extra-
cellular matrices within grafts label solely for donor- (kid-
ney-) derived matrix [8]. To examine directly the origin of
glomerular endothelial and mesangial cells, we grafted E11
to E12 kidneys from wild-type mice into ROSA26 mice,
which are transgenic animals that express b-galactosidase
in every cell [9]. When grafts are developed for b-galacto-
sidase activity, host cells are seen in peripheral vessels, but
the vast majority of glomerular and microvascular endothe-
lial cells are of donor, not host, origin, and mesangial cells
are always of donor origin [8]. Together, these results show
that cells from the implanted kidney are almost entirely
responsible for development of the renal microvasculature
in oculo. External vessels from the host, although important
for graft maintenance, are not major contributors to the
glomerulus [8].
ORGAN CULTURE OF EMBRYONIC KIDNEYS
Although organotypic epithelial tubulogenesis occurs
when kidneys are placed in culture, only avascular glomer-
ular structures form in vitro under normoxic (20% O2)
conditions [2, 3, 10]. Nonvascularized glomeruli in these
organ culture systems consist of differentiated podocytes
replete with foot processes that surround lengthy basement
membrane segments, but no morphologic evidence for
renal blood vessel formation in vitro has been obtained [3,
10]. We cultured E11 to E12 mouse kidneys in vitro for up
to 6 days and labeled the cultures with Bandeiraea simplici-
folia isolectin B4, which binds specifically to embryonic
mouse endothelial cells [11]. Although lectin-labeled mi-
crovessels are seen in freshly harvested E12 kidneys, such
structures are not observed after 6 days in organ culture
[12]. To examine the fate of these organ cultures further,
kidneys that had first been maintained in vitro for 6 days
were then grafted into anterior eye chambers of adult
ROSA26 hosts. Grafts were harvested 7 days after implan-
tation and developed for b-galactosidase activity. These
grafts contain numerous mature glomeruli perfused with
erythrocytes, but the microvasculature within the grafts
does not express the host transgene and is, therefore, of
endogenous origin [12]. This evidence indicates that intrin-
sic endothelial precursors survive organ culture and, upon
grafting, have the capacity to generate the entire kidney
microvasculature in vivo [12].
MECHANISMS OF VASCULAR DEVELOPMENT
Considerable recent evidence has implicated several
growth factor/transmembrane receptor tyrosine kinase
(RTK) systems in mediating early blood vessel formation.
The intrinsic tyrosine kinase activity of these receptors is
activated upon ligand binding at the external cell surface,
which results in phosphorylation of the cytoplasmic tail of
the receptor itself along with other intracellular proteins,
and stimulates a cascade of cellular activities regulating
growth and differentiation [13]. Several potentially relevant
angiogenic growth factors, including acidic and basic fibro-
blast growth factor and platelet-derived growth factor and
their respective RTKs, are expressed in the kidney [14, 15].
Precisely what roles these factors play in metanephric
vascularization have not been firmly established, however.
Characterization of vascular endothelial growth factor
(VEGF) and its two distinct RTKs, which in mice are
referred to as fetal liver kinase (Flk1) and fms-like tyrosine
kinase-1 (Flt1), has shown that this signaling system is
involved directly in endothelial cell commitment and dif-
ferentiation [16]. VEGF and Flk1 are expressed co-ordi-
nately during kidney organogenesis, implying pivotal func-
tions for this receptor/ligand pair in renal blood vessel
development [17, 18]. VEGF is a potent endothelial cell-
specific mitogen that enhances cell migration and induces
serine proteases, all of which are important for angiogen-
esis and, probably, vasculogenesis. VEGF expression has
been demonstrated by in situ hybridization in visceral
epithelial cells of S-shaped bodies of human fetal kidneys
and in glomerular epithelium of E15 mice [18, 19]. To
assess the role of VEGF directly, VEGF gene expression
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has been disrupted in embryonic stem cells [20, 21]. Re-
markably, the loss of a single VEGF allele is lethal in the
;E10.5—E11 mouse embryo, indicating a tight ligand-
dose-dependent effect of VEGF on embryonic vessel de-
velopment [20, 21].
Flk1 has been identified as a marker for some of the
earliest endothelial cells and is first seen in mice at E7 on
differentiating endothelial cells of the blood islands [16,
22]. Mice with targeted Flk1 gene deficiencies die in utero
by E8.5–E9.5 due to a failure of blood island formation,
confirming a critical role for Flk1 in vascular development
[23]. In situ hybridization studies have demonstrated Flk1
expression in most developing organs, including the kidney,
in both human and mouse [18].
ERYTHROPOIETIN-PRODUCING
HEPATOCELLULAR RECEPTORS SIGNAL
CELLULAR RECOGNITION AND AGGREGATION
RESPONSES
The erythropoietin-producing hepatocellular (Eph)
RTK family includes at least 14 distinct receptors that are
expressed in a highly tissue-restricted distribution [15, 24,
25]. What distinguishes Eph from many other RTK families
is that rather than binding soluble growth factors, the
ligands for Eph receptors (ephrins) are glycosylphosphati-
dylinositol-anchored proteins on cell surfaces (ephrin-A
class) or transmembrane proteins (ephrin-B class). This
unique receptor/ligand system is perhaps best understood
in the developing nervous system, where it mediates non-
proliferative organizational signals implicated in axonal
targeting [25]. In addition, the EphA2 receptor expressed
on vascular endothelial cells mediates chemotactic re-
sponses to its ligand ephrin-A1 [26]. This ligand is also
angiogenic in a rabbit corneal angiogenesis assay [26], and
ephrin-B1 induces cultured human renal microvascular
endothelial cells to assemble into capillary-like networks in
vitro [27]. Clearly, the temporal and spatial patterning that
occurs in neural development has striking parallels with
that of vascular development.
KIDNEY IMMUNOLOCALIZATION OF FLK-1, EPH,
AND EPHRIN-POSITIVE CELLS
To examine further the distribution of cells expressing
Flk1, we labeled sections from embryonic and newborn
(developmentally active) and adult (developmentally qui-
escent) kidneys with antibodies against Flk1, EphB1, and
ephrin-B1 [12, 27]. In developing kidneys, these proteins
localized in remarkably similar patterns and were found on
endothelial cells of forming glomeruli and immature mi-
crovessels (Fig. 1 a, b). Labeling was also seen on a
dispersed population of mesenchymal cells in the nephro-
genic, outer cortical zone, which in rodents is actively
producing new nephrons for up to ;7 days after birth [1].
In marked contrast, anti-Flk1 antibody labeling was only
weakly evident within glomeruli of adult kidneys, and all
other vascular structures were negative (Fig. 1c). These
Fig. 1. Immunofluorescence micrographs of newborn mouse kidney cortex (a and b) and adult mouse cortex (c). Flk1 and EphB1 are distributed in
similar patterns in vascular clefts (VC), developing glomeruli (G), and vessels and on discrete membrane domains on cortical mesenchymal cells in
newborn kidney (a, b). In adult kidney (c), Flk1 only labels glomeruli (G); other vascular structures are negative (3300). See [12] and [27] for details.
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protein immunolocalization results for Flk1 closely corre-
spond to in situ hybridization studies carried out previously
and that show relatively high levels of Flk1 expression in
developing kidney and only very low levels of transcripts in
adults [18]. EphB1 and ephrin-B1 protein persist in adult
renal arteries, arterioles, and glomeruli but are not found
elsewhere in the kidney [27].
INTRARENAL GRAFTS INTO NEWBORN AND
ADULT HOSTS
Having identified Flk1-positive, candidate angioblasts in
the outer cortex of newborn kidneys, we sought to test
the ability of these cells to form microvessels in vivo. For
these experiments, E12 kidneys from normal donors were
grafted under the renal capsule of both newborn and adult
ROSA26 hosts [12]. When grafts were established in the
outer cortex of adult kidneys, a site that does not contain
dispersed Flk1, EphB1, or ephrin-B1-positive mesenchymal
cells, the vasculature within these grafts was of intrinsic,
donor origin [12]. In contrast, when kidneys were grafted
into neonatal cortices, an environment rich in Flk1, Eph,
and ephrin-positive cells, most glomeruli within grafts
contained endothelium derived from the host neonatal
kidney (Fig. 2). Large amounts of extraglomerular micro-
vasculature within these grafts were also of host origin.
Because the outer cortex of host newborn kidneys is also
engaged in microvessel formation, we reasoned that angio-
blasts from the graft might be able to migrate from the graft
and incorporate into host vessels forming in the vicinity. To
test this premise, E12 kidneys from ROSA26 mice were
grafted into neonatal renal cortices of normal, wild-type
hosts. Indeed, cells expressing the graft-derived transgene
were found intercalating into host endothelium, creating
chimeric vessels (Fig. 3) [12].
To recapitulate, using antibodies against Flk1, the earli-
est known marker for endothelial cells, we have identified a
discrete population of candidate angioblasts dispersed
throughout the E12 kidney and located in the outer cortex
of newborn mouse kidneys. Using anterior eye chamber
and intrarenal grafts, we have demonstrated the vasculo-
genic potential in vivo of these dispersed Flk1-positive cells.
Taken together, our data strongly suggest that at least some
of the metanephric mesenchymal cells expressing Flk1 are
Fig. 2. Micrograph showing graft of embryo day 12 (E12) wild-type mouse kidney into newborn ROSA26 host, 7 days after grafting. Numerous
microvessels throughout graft, as well as vascular clefts of S-shaped figures (arrowheads) and developing glomeruli (G), contain b-galactosidase—
positive, and therefore host-derived, endothelium. Host kidney tissue is on upper right-hand corner (3300). See [12] for details.
Fig. 3. Graft of an E12 ROSA26 kidney into a wild-type newborn host
kidney cortex. Other details as in Figure 2. Note chimeric vessel containing
b-galactosidase-positive (arrows 5 graft-derived) and normal (arrow-
heads 5 host-derived) endothelium (3550) [12].
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endothelial progenitors that form the microvasculature of
the developing kidney, and cells expressing EphB1 and
ephrin-B1 likely participate as well.
Our in vitro and grafting experiments summarized here
have not definitively shown, however, whether renal mi-
crovessels normally arise by vasculogenesis exclusively.
Indeed, some studies we have recently undertaken using
heterozygote Flk-1tm1Jrt animals with one functional Flk1
allele suggest that there is an important angiogenic com-
ponent during early metanephrogenesis, and a combination
of angiogenic and vasculogenic events probably occur
thereafter [28]. Exactly how Flk1/VEGF and EphB1/
ephrin-B1 mediate microvascular assembly is also not clear.
Because these distinct receptor/ligand systems are ex-
pressed in similar patterns, our current speculation is that
Flk1/VEGF activates endothelial progenitor mitosis and
motility, and Eph/ephrin are involved with spatial guidance
and aggregation of differentiating endothelial cells. Future
studies in which selective components of these signaling
systems are disrupted should help clarify these issues.
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